Mammography Use in Portugal: National Health Survey 2014
Conclusion The combined use of DW-MRI with quantitative ADC data and single-voxel 1H-MRS is a reliable non-contrast tool that provides higher accuracy in characterizing suspicious breast, and can efficiently be used in the absence of DCE-MRI.
Conclusions FNAC was a good cytological predictor in the majority of patients with abnormal lymph nodes and nonspecific mammography. FNAC is cost effective in assessing axillary lymph node status especially in limited resource setting like in our developing country. FNAC is preferred diagnostic tool in all cases of abnormal axillary lymph adenopathy.
Patient navigation services can be a helpful way to support cancer screening...Read more on AuntMinnie.comRelated Reading: Breast MR: Is it accessible to women who need it? NCoBC: 3 ways nurse navigators can reduce your malpractice risk NCoBC: Mammography techs play crucial role in women's health NCBC signs deal to train health navigators Patient navigation speeds breast cancer diagnosis
The dose reference parameter in 2D mammography is the mean glandular dose (MGD) , i.e. the dose, on average, to the glandular tissue of the breast undergoing the exam. Following several protocols worldwide [2 –5], the MGD is estimated from measurement of the air kerma at the entrance skin surface of the compressed breast, multiplied by suitable conversion coefficients: the normalized glandular dose (DgN) coefficients [6,7] or the set of (g, c, s) coefficients [8,9]. These coefficients depend on the bea m characteristics, as well as on the breast anatomy, such as the compressed thickness and the glandular fraction.
Abstract Screening mammography reduces breast cancer mortality in average-risk women. However, adverse consequences include false-positive findings possibly leading to benign breast biopsies and patient anxiety. There is also potential for overdiagnosis and overtreatment. Differences in how to balance benefits and harms have led to varying recommendations by the U.S. Preventive Services Task Force, the American Cancer Society, the National Comprehensive Cancer Network and the American College of Radiology/Society of Breast Imaging. These recommendations differ with respect to what age to start, what age to stop, a...
The Breast Journal, EarlyView.
Patients who previously had a false-positive breast or prostate cancer screening...Read more on AuntMinnie.comRelated Reading: Geography, lack of specialization hinder imaging access Is Google News good for mammography? Mammography guidelines don't change screening intervals ACOs boost use of screening mammography False positives don't deter women from mammography
Condition: Atypical Ductal Hyperplasia Intervention: Device: Contrast enhanced mammography Sponsors: Dana-Farber Cancer Institute; GE Healthcare Not yet recruiting
These scares are common. They affect about half of women who get annual mammograms; almost one-quarter of those who get regular stool tests for colon cancer; and 10 to 12 percent of men who have regular prostate cancer tests, the researchers said.
Overdiagnosis of breast cancer -- that is, the detection of cancer on screening...Read more on AuntMinnie.comRelated Reading: Does double reading improve breast cancer screening? Is screening breast MRI being used in the wrong women? Is the mammography debate an example of 'fake science'? Women still value mammography's benefits over 'harms' Do older women benefit from screening mammography?